Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates
06. November 2017 07:30 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Health Insurance Innovations, Inc. Reports Record Third Quarter 2017 Financial and Operating Results
01. November 2017 16:05 ET
|
Health Insurance Innovations, Inc.
Increases 2017 Full Year GuidanceRecord Revenues of $63.3 million, up 37% YOYDiluted Earnings per Share of $0.30, up 20% YOYAdjusted Earnings per Share of $0.46, up 39% YOYPolicies in Force totaled...